NCIC Clinical Trials Group

πŸ‡¨πŸ‡¦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density

Phase 2
Completed
Conditions
Interventions
First Posted Date
2005-10-13
Last Posted Date
2020-04-02
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
68
Registration Number
NCT00238316
Locations
πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

πŸ‡¨πŸ‡¦

Nova Scotia Cancer Centre, Halifax, Nova Scotia, Canada

πŸ‡¨πŸ‡¦

Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada

and more 7 locations

AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)

First Posted Date
2005-04-06
Last Posted Date
2023-08-04
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
50
Registration Number
NCT00107250
Locations
πŸ‡¨πŸ‡¦

Ottawa Hospital Regional Cancer Centre - General Campus, Ottawa, Ontario, Canada

πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

SB-715992 in Treating Patients With Metastatic or Recurrent Malignant Melanoma

Phase 2
Completed
Conditions
First Posted Date
2004-11-09
Last Posted Date
2013-05-17
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
17
Registration Number
NCT00095953
Locations
πŸ‡¨πŸ‡¦

Fraser Valley Cancer Centre at British Columbia Cancer Agency, Surrey, British Columbia, Canada

πŸ‡¨πŸ‡¦

British Columbia Cancer Agency - Vancouver Cancer Centre, Vancouver, British Columbia, Canada

πŸ‡¨πŸ‡¦

Toronto Sunnybrook Regional Cancer Centre at Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada

and more 4 locations

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-11-09
Last Posted Date
2023-08-04
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
15
Registration Number
NCT00095992
Locations
πŸ‡¨πŸ‡¦

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

πŸ‡¨πŸ‡¦

Cancer Centre of Southeastern Ontario at Kingston, Kingston, Ontario, Canada

πŸ‡¨πŸ‡¦

Univ. Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada

and more 1 locations

Sorafenib in Treating Patients With Metastatic or Recurrent Prostate Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-10-08
Last Posted Date
2023-08-04
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
28
Registration Number
NCT00093457
Locations
πŸ‡¨πŸ‡¦

CancerCare Manitoba, Winnipeg, Manitoba, Canada

πŸ‡¨πŸ‡¦

Princess Margaret Hospital, Toronto, Ontario, Canada

πŸ‡¨πŸ‡¦

Tom Baker Cancer Centre - Calgary, Calgary, Alberta, Canada

and more 4 locations

Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease

First Posted Date
2004-08-31
Last Posted Date
2020-04-06
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
67
Registration Number
NCT00002570
Locations
πŸ‡ΊπŸ‡Έ

Quain & Ramstad Clinic, P.C., Bismarck, North Dakota, United States

πŸ‡ΊπŸ‡Έ

Rapid City Regional Hospital, Rapid City, South Dakota, United States

πŸ‡ΊπŸ‡Έ

CCOP - Iowa Oncology Research Association, Des Moines, Iowa, United States

and more 13 locations

Pilocarpine in Treating Patients With Dry Mouth Caused by Opioids

First Posted Date
2004-08-17
Last Posted Date
2020-04-03
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
4
Registration Number
NCT00003686
Locations
πŸ‡¨πŸ‡¦

BC Cancer Agency, Vancouver, British Columbia, Canada

πŸ‡¨πŸ‡¦

Humber River Regional Hospital, Weston, Ontario, Canada

Theophylline in Treating Cancer Patients With Shortness of Breath

First Posted Date
2004-08-17
Last Posted Date
2020-04-03
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
3
Registration Number
NCT00003684
Locations
πŸ‡¨πŸ‡¦

Kingston Regional Cancer Centre, Kingston, Ontario, Canada

πŸ‡¨πŸ‡¦

Algoma District Medical Group, Sault Sainte Marie, Ontario, Canada

πŸ‡¨πŸ‡¦

Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada

and more 1 locations

ISIS 5132 in Treating Patients With Metastatic or Recurrent Ovarian Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2004-08-05
Last Posted Date
2020-04-06
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
22
Registration Number
NCT00003892
Locations
πŸ‡¨πŸ‡¦

Northwestern Ontario Regional Cancer Centre, Thunder Bay, Thunder Bay, Ontario, Canada

πŸ‡¨πŸ‡¦

Cancer Care Ontario-London Regional Cancer Centre, London, Ontario, Canada

πŸ‡¨πŸ‡¦

Centre Hospitalier Universitaire de Quebec, Pavillion de Quebec, Quebec City, Quebec, Canada

and more 63 locations

Tamoxifen in Treating Women With High-Risk Breast Cancer

Phase 3
Completed
Conditions
First Posted Date
2004-07-29
Last Posted Date
2020-04-01
Lead Sponsor
NCIC Clinical Trials Group
Target Recruit Count
672
Registration Number
NCT00002542
Locations
πŸ‡¨πŸ‡¦

Credit Valley Hospital, Mississauga, Canada

πŸ‡¨πŸ‡¦

Cancer Centre of Southeastern Ontario at Kingston, Kingston, Canada

πŸ‡¨πŸ‡¦

Stronach Regional Health Centre at Southlake, Newmarket, Canada

and more 45 locations
Β© Copyright 2024. All Rights Reserved by MedPath